Ci Design Acquires Compounding Workflow
September 11, 2023
Ci Design has acquired Compounding Workflow, a laboratory design and compounding pharmacy consulting practice owned by Bryan Prince, and opened a new office in Greenville, South Carolina. Prince joins Ci as an Associate and Senior Lab Planner to expand Ci's compounding pharmacy and USP-compliant lab design expertise across the firm's Science & Technology practice.
- Buyers
- Ci Design
- Targets
- Compounding Workflow
- Industry
- Professional Services
- Location
- South Carolina, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Sterling Pharma Solutions Acquires CiVentiChem US Facility in Cary, North Carolina
April 3, 2019
Pharmaceuticals
UK-based CDMO Sterling Pharma Solutions, a portfolio company of GHO Capital, has acquired the CiVentiChem US facility in Cary, North Carolina to establish a local presence for its North American clients and expand its chemistry development and kilo-scale cGMP capabilities. The acquisition supports Sterling’s strategy to build a global chemistry services business and follows GHO Capital’s majority investment in Sterling earlier this year.
-
Fagron Acquires University Compounding Pharmacy (UCP)
January 12, 2026
Pharmaceuticals
Fagron NV has completed the acquisition of University Compounding Pharmacy (UCP), a San Diego–based 503A compounding pharmacy focused on health and wellness, hormones and urology. The transaction has an enterprise value of approximately $41.5 million; UCP had annual revenues of around $25 million and will be integrated to strengthen Fagron's U.S. compounding platform alongside Anazao, with synergies expected over 18–24 months.
-
Fagron Completes Acquisition of University Compounding Pharmacy (UCP)
January 12, 2026
Pharmaceuticals
Fagron has completed the acquisition of University Compounding Pharmacy (UCP), a San Diego–based 503A compounding pharmacy focused on hormone and urology therapies. The transaction values UCP at approximately $41.5 million; UCP generates roughly $25 million of annual revenue. Fagron said the purchase supports its strategy to build a nationwide U.S. compounding platform (complementary to Anazao) and strengthens its presence in California.
-
Computer Design & Integration (CDI) Acquires Plan B Technologies, Inc.
July 7, 2020
IT Services
Computer Design & Integration LLC (CDI), a PE-backed IT infrastructure and managed services provider, has acquired Plan B Technologies, Inc., an Annapolis-based IT solutions and professional services firm. Backed by One Equity Partners, the acquisition is an add-on to CDI's growth strategy to expand service capabilities (notably virtualization and cloud/backup solutions) and extend sales reach across the eastern U.S.; financial terms were not disclosed.
-
Columbia PSI Acquires Control Design & Manufacturing
April 1, 2022
Manufacturing
Columbia PSI, LLC (a business unit of Columbia Machine, Inc.) acquired Control Design & Manufacturing, Inc., a Denver-area designer and manufacturer of bag palletizing, bag handling and box forming/filling equipment. The transaction, which closed April 1, 2022, brings CD&M's palletizing and controls capabilities into Columbia PSI's bagging and packaging product line while retaining CD&M employees in the Denver operation.
-
Jabil Acquires Pharmaceutics International (Pii)
February 6, 2025
Pharmaceuticals
Jabil has acquired Pharmaceutics International (Pii), a Hunt Valley, Maryland-based contract development and manufacturing organization (CDMO) that provides aseptic filling, lyophilization and oral solid dose manufacturing. The all-cash transaction represents an exit for a consortium led by Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital and Pharmascience Inc., and brings Pii’s ~300+ employees and four-site campus into Jabil’s Pharmaceutical Solutions offering to expand its drug development and manufacturing capabilities.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.